1. Drug Repurposing Opportunities in Pancreatic Ductal Adenocarcinoma
   Rita Rebelo et al, 2021, Pharmaceuticals CrossRef
2. Metformin and Cancer, an Ambiguanidous Relationship
   Sarah J. Skuli et al, 2022, Pharmaceuticals CrossRef
3. Resistance to Gemcitabine in Pancreatic Ductal Adenocarcinoma: A Physiopathologic and Pharmacologic Review
   Tomas Koltai et al, 2022, Cancers CrossRef
4. Diabetes and pancreatic cancer: Exploring the two-way traffic
   Ayan Roy et al, 2021, World Journal of Gastroenterology CrossRef
5. Repurposed Biguanide Drugs in Glioblastoma Exert Antiproliferative Effects via the Inhibition of Intracellular Chloride Channel 1 Activity
   Federica Barbieri et al, 2019, Frontiers in Oncology CrossRef
6. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways
   José Esparza-López et al, 2019, BMC Cancer CrossRef
7. The Impact of Epithelial–Mesenchymal Transition and Metformin on Pancreatic Cancer Chemoresistance: A Pathway towards Individualized Therapy
   Aiste Gulla et al, 2022, Medicina CrossRef
8. Effects of TP53 Mutations and miRs on Immune Responses in the Tumor Microenvironment Important in Pancreatic Cancer Progression
   James A. McCubrey et al, 2022, Cells CrossRef
9. Honokiol Suppresses Perineural Invasion of Pancreatic Cancer by Inhibiting SMAD2/3 Signaling
   Tao Qin et al, 2021, Frontiers in Oncology CrossRef